Cannabidiol for Treatment of Child and Adolescent Psychiatric Disorders

被引：0
|
作者：
Melnyk, Charlena Janice [1 ]
Wagner, Karen Dineen [1 ]
机构：
[1] Univ Texas Med Branch, Dept Psychiat & Behav Sci, Galveston, TX USA
来源：
PSYCHIATRIC ANNALS | 2024年 / 54卷 / 06期
关键词：
ANXIETY; INVENTORY; SCALE; VALIDATION; WITHDRAWAL; STATES;
D O I：
10.3928/00485713-20240320-01
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
Parents and patients have inquired about the safety and efficacy of cannabidiol (CBD) in treating child and adolescent mental health conditions. This review examines the current literature regarding CBD containing less than 0.3% tetrahydrocannabinol ( THC) in treatment of childhood psychiatric disorders for youth 20 years and younger. Although there are several areas of growing interest for potential use of CBD, such as social anxiety disorder and autism spectrum disorder, the evidence base remains limited. Large-scale controlled trials are needed to determine the efficacy of CBD for treatment of child and adolescent psychiatric disorders.
引用
收藏
页码：e186 / e192
页数：7
相关论文
共 50 条
12345